BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28778431)

  • 1. The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro.
    Alvarenga MP; Fernandez O; Leyva L; Campanella L; Vasconcelos CF; Alvarenga M; Papais Alvarenga RM
    J Neuroimmunol; 2017 Sep; 310():1-7. PubMed ID: 28778431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is neuromyelitis optica associated with human leukocyte antigen?
    Zéphir H; Fajardy I; Outteryck O; Blanc F; Roger N; Fleury M; Rudolf G; Marignier R; Vukusic S; Confavreux C; Vermersch P; de Seze J
    Mult Scler; 2009 May; 15(5):571-9. PubMed ID: 19299434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.
    Deschamps R; Paturel L; Jeannin S; Chausson N; Olindo S; Béra O; Bellance R; Smadja D; Césaire D; Cabre P
    Mult Scler; 2011 Jan; 17(1):24-31. PubMed ID: 20861181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
    Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
    J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA DRB1-DQB1 Haplotypes with the Risk for Neuromyelitis Optica among South Indians.
    Kanikannan MA; Kathgave R; Yareeda S; Katkam SK; Kumaraswamy K; Kutala VK
    Neurol India; 2022; 70(4):1481-1486. PubMed ID: 36076647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica].
    Blanco Y; Ercilla-González G; Llufriu S; Casanova-Estruch B; Magraner MJ; Ramió-Torrentá L; Mendibe-Bilbao MM; Uclés-Sánchez AJ; Casado-Chocán JL; López de Munain A; Ramo-Tello C; Santos-Lasaosa S; Fernández-Bolaños Porras R; Segura-Bruna N; Sepulveda-Gázquez M; Villoslada P; Graus F; Saiz A
    Rev Neurol; 2011 Aug; 53(3):146-52. PubMed ID: 21748712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
    Brum DG; Barreira AA; dos Santos AC; Kaimen-Maciel DR; Matiello M; Costa RM; Deghaide NH; Costa LS; Louzada-Junior P; Diniz PR; Comini-Frota ER; Mendes-Junior CT; Donadi EA
    Mult Scler; 2010 Jan; 16(1):21-9. PubMed ID: 19995845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica.
    Asgari N; Nielsen C; Stenager E; Kyvik KO; Lillevang ST
    Mult Scler; 2012 Jan; 18(1):23-30. PubMed ID: 21908482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences.
    Alonso VR; de Jesus Flores Rivera J; Garci YR; Granados J; Sanchez T; Mena-Hernandez L; Corona T
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):4-7. PubMed ID: 26923907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
    Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
    Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.
    Watanabe M; Nakamura Y; Sato S; Niino M; Fukaura H; Tanaka M; Ochi H; Kanda T; Takeshita Y; Yokota T; Nishida Y; Matsui M; Nagayama S; Kusunoki S; Miyamoto K; Mizuno M; Kawachi I; Saji E; Ohashi T; Shimohama S; Hisahara S; Nishiyama K; Iizuka T; Nakatsuji Y; Okuno T; Ochi K; Suzumura A; Yamamoto K; Kawano Y; Tsuji S; Hirata M; Sakate R; Kimura T; Shimizu Y; Nagaishi A; Okada K; Hayashi F; Sakoda A; Masaki K; Shinoda K; Isobe N; Matsushita T; Kira JI
    Sci Rep; 2021 Jan; 11(1):607. PubMed ID: 33436735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
    Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-alleles class I and II associated with genetic susceptibility to neuromyelitis optica in Brazilian patients.
    Kay CSK; Scola RH; Arndt RC; Lorenzoni PJ; Werneck LC
    Arq Neuropsiquiatr; 2019 May; 77(4):239-247. PubMed ID: 31090804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA associations with multiple sclerosis in Greece.
    Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
    J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis.
    Alvarenga MP; do Carmo LF; Vasconcelos CCF; Alvarenga MP; Alvarenga-Filho H; de Melo Bento CA; Paiva CLA; Leyva-Fernández L; Fernández Ó; Papais-Alvarenga RM
    Sci Rep; 2021 Jan; 11(1):152. PubMed ID: 33420337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.